ElectroWire Medical has received U.S. FDA 510(k) clearance for its LightningWire Transseptal Puncture System, a device indicated to create an atrial septal defect in the heart for the introduction of cardiovascular catheters.

The system combines an electrosurgical guidewire with a dedicated activation cable, allowing physicians to use preferred transseptal introducers and existing electrosurgical generators. ElectroWire said the system is designed to simplify transseptal puncture while supporting broad compatibility across different cardiovascular procedures.

This is relevant because transseptal access is a critical step in many left-sided heart interventions. Procedures such as catheter ablation for atrial fibrillation, left atrial appendage occlusion and transcatheter mitral valve repair or replacement often depend on safe and controlled access across the atrial septum.